Eden Share News (EDEN)

Eden Research bounces on first commercial order for Mevalone

(ShareCast News) - Eden Research has received its first order for its Mevalone grape crop treatment from partner K&N Efthymiadis that will generate first revenue from the agreement. K&N Efthymiadis, which is an arm of Greek agribusiness group Redestos, has placed placed its first order for Mevalone

WINNERS & LOSERS SUMMARY: Roxanne Labs Revenue Miss Hits Hikma Shares

Eden Research's Greek Partner Places 1st Order For Botrytis Treatment

Eden Research Gets 3AEY Commercial Sale Approval In Bulgaria

LONDON MARKET MIDDAY: Stocks Recover From Shock Of Paris Attacks

WINNERS & LOSERS SUMMARY: Paris Attacks Weigh On Travel Companies

Eden Research Kenya Partner Gets 3AEY Approval, Makes Initial Order

Eden Research Inks Collaboration Deal With Intellectual Ventures

WINNERS & LOSERS SUMMARY: ARM Rises Amid Growth Plans, iPhone Sales

BROKER RATINGS SUMMARY: UBS Initiates Legal & General With Sell

Eden Research Narrows Loss As It Works Towards Product Approvals

Eden Research Says 3AEY Fungicide Gets Greek Market Approval

Eden Research Inks Licence Deal With TerpeneTech, Takes 29.9% Stake (ALLISS)

CORRECT: WINNERS & LOSERS: Ex-Dividend Companies Weigh On Indices

WINNERS & LOSERS: Ex-Dividend Companies Weigh On Main London Indices